Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes - Salminen, Heidi J.; Leggett, Helen; Boggild, Mike (Journal of neurology, 2010)
Keywords: Abnormalities, Drug-Induced - diagnosis; Abnormalities, Drug-Induced - epidemiology; Adjuvants, Immunologic - administration & dosage; Adjuvants, Immunologic - adverse effects; Adult; Biological and medical sciences; Birth defects; Delivery. Postpartum. Lactation; Disorders; Drug withdrawal; Female; Glatiramer Acetate; Gynecology. Andrology. Obstetrics; Humans; Immunosuppressive Agents - administration & dosage; Immunosuppressive Agents - adverse effects; Interferon; Medical sciences; Medicine; Medicine & Public Health; Miscarriage; Multiple sclerosis; Multiple Sclerosis - drug therapy; Neurology; Neuroradiology; Neurosciences; Original Communication; Peptides - administration & dosage; Peptides - adverse effects; Pregnancy; Pregnancy Complications - chemically induced; Pregnancy Complications - diagnosis; Pregnancy Outcome - epidemiology; Prospective Studies; Risk Factors; Surveillance; Womens health; Glatiramer acetate; Pregnancy; Multiple sclerosis; Nervous system diseases; Prognosis; Central nervous system disease; Safety; Inflammatory disease